...
首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Significance of notch1-signaling pathway in human pancreatic development and carcinogenesis
【24h】

Significance of notch1-signaling pathway in human pancreatic development and carcinogenesis

机译:Notch1信号通路在人类胰腺发育和癌变中的意义

获取原文
获取原文并翻译 | 示例
           

摘要

In animal studies, Notch1-signaling pathway plays an important role in the pancreatic embryogenesis by promoting pancreatic progenitor cells self-renewal and exocrine linage development. The persistent activation of Notch pathway could arrest the organ development and keep cells at an undifferentiated stage. Studies have shown that Notch1-signaling pathway is upregulated in invasive pancreatic ductal adenocarcinoma (PDAC). Here we examined the expression pattern of Notch1 and Hes1 in human fetal pancreatic tissues to elucidate the role of Notch1 in human pancreatic embryonic development. We also compared Notch1 expression in tissues from PDAC, chronic pancreatitis and pancreatic intraepithelial neoplasm. Our data show that Notch1/Hes1-signaling pathway is activated during early pancreatic embryogenesis and reaches the highest at birth. After pancreas is fully developed, Notch1/Hes1 pathway is inactivated even though Notch1 protein cell-surface expression is upregulated. We also showed that the expression of both Notch1 and Hes1 are present in 50% (33/66) of PDACs, but not in pancreatic intraepithelial neoplasms. These findings indicate that Notch1 activation is only apparent in late stage of pancreatic carcinogenesis, suggesting that treatment with Notch-signaling inhibitors including γ-secretase should be selectively used for PDACs with confirmed Notch1-signaling activation.
机译:在动物研究中,Notch1信号通路通过促进胰腺祖细胞的自我更新和外分泌的线性表达,在胰腺胚胎发生中起重要作用。 Notch途径的持续激活可以阻止器官的发育并使细胞保持未分化的阶段。研究表明,Notch1信号通路在侵袭性胰腺导管腺癌(PDAC)中上调。在这里,我们检查了Notch1和Hes1在人类胎儿胰腺组织中的表达模式,以阐明Notch1在人类胰腺胚胎发育中的作用。我们还比较了Notch1在PDAC,慢性胰腺炎和胰腺上皮内肿瘤组织中的表达。我们的数据显示,Notch1 / Hes1信号通路在早期胰腺胚胎发生过程中被激活,并在出生时达到最高。胰腺完全发育后,即使Notch1蛋白细胞表面表达上调,Notch1 / Hes1途径也会失活。我们还显示,Notch1和Hes1的表达均存在于50%(33/66)的PDAC中,但在胰腺上皮内肿瘤中却不存在。这些发现表明,Notch1激活仅在胰腺癌发生的晚期才出现,这表明用Notch信号抑制剂(包括γ-分泌酶)进行的治疗应选择性用于已证实Notch1信号激活的PDAC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号